London
Roots Analysis has announced the
addition of “Antibody
Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of
offerings.
The development of such biologics is inherently
complex, and many drug developers are now seeking to optimize R&D
efficiency and affiliated costs. As a result, innovator companies are
outsourcing most of their discovery-stage operations to specialty contract
research organizations (CROs), which offer a plethora of advanced technologies
to cater to the evolving needs. It is also worth highlighting that stakeholders
engaged in this domain are actively undertaking initiatives to develop
interventions for SARS-CoV-2 virus.
To order this 450+ page report, which
features 120+ figures and 140+ tables, please visit this link
Key Market
Insights
Presently,
more than 80 players claim to offer services for antibody discovery
Over 90% of the
aforementioned players provide services for hit generation, followed by those
offering services for antibody humanization (58%). It is worth mentioning that
five service providers claim to have the required expertise to serve as
one-stop-shops for all the antibody discovery steps.
More than
120 companies offer antibody discovery platforms
It is
worth highlighting that close to 180 technologies focused on antibody discovery
are presently available in the market. Further, nearly 50% platforms use
library-based methods to discover antibodies. Amongst these, phage display is
currently the most widely used technique. This is followed by single cell-based
methods (20%).
Partnership
activity within this domain has grown at a CAGR of 18%, between 2015 and 2020
In the
last five years, more than 400 agreements were inked related to antibody
discovery, with the maximum activity being reported in 2018. Majority of
partnership deals signed within this domain were licensing agreements (25%),
product development and commercialization agreements (24%), and R&D
agreements (18%).
Nearly USD 7 billion has been invested in the antibody discovery
domain, during 2016-2020
The
aforementioned amount was raised across more than 140 funding instances. It is
important to mention that, in 2019-2020, over USD 2 billion was raised by
antibody discovery service and platform providers across close to 40 instances.
Majority of the funding in this year was acquired through venture capital
rounds (42%), grants (20%), and instances of initial public offering (10%).
The
antibody discovery services market is anticipated to be worth over USD 6
billion by 2030
Majority of the market opportunity (60%) is expected
to be generated from antibody services offered through phage display and
hybridoma based methods, followed by those using transgenic animal based
methods; this trend is unlikely to change in the foreseen future as well.
The
licensing market opportunity for antibody discovery platforms is anticipated to
grow at a CAGR of close to 10%, during 2020-2030
By 2030, North
America is estimated to capture over 50% (in terms of revenues generated)
share of the antibody discovery platforms market.
It is worth mentioning that the market for antibody discovery platforms in Asia-pacific
is anticipated to grow at a relatively faster pace, during the forecast period.
To request a sample copy / brochure of this
report, please visit this link
Key
Questions Answered
§
§
§
§
§
§
§
The USD 6.5
billion (by 2030) financial opportunity within the antibody discovery services market
has been analyzed across the following segments:
§
- Antigen Designing
- Hit Generation
- Lead Selection
- Lead Optimization
- Lead Characterization
§
- Phage Display
- Hybridoma
- Transgenic Animal
- Yeast Display
- Single Cell
- Others
§
- Humanized
- Human
- Chimeric
- Murine
§
- North America
- Europe
- Asia Pacific and Rest of the World
The USD 5.9
billion (by 2030) financial opportunity within the antibody discovery platforms
market has been analysed across the following segments:
§
- Upfront Payments
- Milestone Payments
§
- North America
- Europe
- Asia Pacific
The
report features inputs from eminent industry stakeholders, according to whom, in
the foreseen future, competition within
antibody discovery services and platforms is expected to grow
significantly, resulting in an increase in the overall market value. The report
includes detailed transcripts of discussions held with the following experts:
§
§
§
§
§
§
§
§
§
§
§
§
§
The
research includes detailed profiles of key players (listed below); each
profile features an overview of the company, its financial information (if available), a description
of the platform(s) / service(s) offered, details of recent developments related
to antibody discovery and an informed future outlook.
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
For additional details, please
visit
or email sales@rootsanalysis.com
You may also be interested in the
following titles:
1.
2.
3.
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
